Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-Year results

British Journal of Ophthalmology

Volumn 96, Issue 4, 2012, Pages 499-502

  Abramson, David H ^a   Marr, Brian P ^a   Dunkel, Ira J ^a   Brodie, Scott ^b   Zabor, Emily C ^a   Driscoll, Sarah J ^a   Gobin, Y Pierre ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRORETINOGRAM; ENUCLEATION; EVENT FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; TUMOR SEEDING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CHOROID NEOPLASMS; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NEOPLASM SEEDING; OPHTHALMIC ARTERY; OPHTHALMOSCOPY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VITREOUS BODY; YOUNG ADULT;

EID: 84858300503     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300498     Document Type: Article

References (25)

1. Kim JW, Abramson DH, Dunkel IJ. Current management strategies for intraocular retinoblastoma. Drugs 2007;67:2173-85. (Pubitemid 47557093)
2. Reese AB. Tumors of the Eye. 2nd edn. New York, NY: Harper & Row, 1963:368-77.
3. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-17. (Pubitemid 30036331)
4. Antonelli CB, Ribeiro KC, Steinhorst F, et al. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol 2006;28:342-5. (Pubitemid 43970388)
5. Kim JH, Yu YS, Khwarg SI, et al. Clinical result of prolonged primary chemotherapy in retinoblastoma patients. Korean J Ophthalmol 2003;17:35-43.
6. Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol 2004;122:1316-23. (Pubitemid 39180851)
7. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol 2003;33:601-7. (Pubitemid 43102812)
8. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64. (Pubitemid 34462014)
9. Gunduz K, Gunalp I, Yalcindag N, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 2004;111:1917-24. (Pubitemid 39311847)
10. Abramson DH, Ellsworth RM, Rosenblatt M, et al. Retreatment of retinoblastoma with external beam irradiation. Arch Ophthalmol 1982;100:1257-60. (Pubitemid 12097216)
11. Chan MPY, Hungerford JL, Kingston JE, et al. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Br J Ophthalmol 2009;93:891-4.
12. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115:1398-404.
13. Abramson DH. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture. Br J Ophthalmol 2010;94:396-9.
14. Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 2011;129:732-7.
15. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol 1963;67:164-72.
16. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 2004;9:1-6. (Pubitemid 38470656)
17. Shields CL, Mashayekhi A, Cater J, et al. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Trans Am Ophthalmol Soc 2004;102:35-45. (Pubitemid 40706040)
18. Shields CL, Honavar SG, Shields JA, et al. Factors predictive of recurrence o retinal tumors, vitreous seeds and subretinl seeds following chemoreduction for retinobastoma. Arch Ophthal 2002;120:460-4. (Pubitemid 34727817)
19. Beck NM, Balmer A, Dessing P, et al. First-Line Chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin Oncol 2000;18:2881-6.
20. Qian J, Xue K, Gao YJ, et al. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma]. Zhongua Yan Ke Za Zhi 2010;46:312-16.
21. Novetsky DE, Abramson DH, Kim JW, et al. Published international classification of retinoblastoma (ICRB) definitions contain inconsistenciesdan analysis of impact. Ophthalmic Genet 2009;30:40-4.
22. Kingston JE, Hungerford JL, Madreperla SA, et al. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996;114:1339-43. (Pubitemid 26398719)
23. Murphree AL, Villablanca JG, Deegan WF 3rd, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1348-56. (Pubitemid 26398720)
24. Greenwald MJ, Goldman S, Strauss LC. CCombined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 1998;105:1579-81. (Pubitemid 28513499)
25. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003;21:2019-25. (Pubitemid 46606392)